No Excess of Mitochondrial DNA Deletions Within Muscle in Progressive Multiple Sclerosis
Overview
Affiliations
Background: Mitochondrial dysfunction is an established feature of multiple sclerosis (MS). We recently described high levels of mitochondrial DNA (mtDNA) deletions within respiratory enzyme-deficient (lacking mitochondrial respiratory chain complex IV with intact complex II) neurons and choroid plexus epithelial cells in progressive MS.
Objectives: The objective of this paper is to determine whether respiratory enzyme deficiency and mtDNA deletions in MS were in excess of age-related changes within muscle, which, like neurons, are post-mitotic cells that frequently harbour mtDNA deletions with ageing and in disease.
Methods: In progressive MS cases (n=17), known to harbour an excess of mtDNA deletions in the central nervous system (CNS), and controls (n=15), we studied muscle (paraspinal) and explored mitochondria in single fibres. Histochemistry, immunohistochemistry, laser microdissection, real-time polymerase chain reaction (PCR), long-range PCR and sequencing were used to resolve the single muscle fibres.
Results: The percentage of respiratory enzyme-deficient muscle fibres, mtDNA deletion level and percentage of muscle fibres harbouring high levels of mtDNA deletions were not significantly different in MS compared with controls.
Conclusion: Our findings do not provide support to the existence of a diffuse mitochondrial abnormality involving multiple systems in MS. Understanding the cause(s) of the CNS mitochondrial dysfunction in progressive MS remains a research priority.
Age-related decline in cerebral oxygen consumption in multiple sclerosis.
Knudsen M, Vestergaard M, Lindberg U, Simonsen H, Frederiksen J, Cramer S J Cereb Blood Flow Metab. 2024; 44(6):1039-1052.
PMID: 38190981 PMC: 11318400. DOI: 10.1177/0271678X231224502.
Licht-Mayer S, Campbell G, Canizares M, Mehta A, Gane A, McGill K Acta Neuropathol. 2020; 140(2):143-167.
PMID: 32572598 PMC: 7360646. DOI: 10.1007/s00401-020-02179-x.
Recent advances in understanding multiple sclerosis.
Stys P, Tsutsui S F1000Res. 2019; 8.
PMID: 31885862 PMC: 6915812. DOI: 10.12688/f1000research.20906.1.
Hargreaves I, Mody N, Land J, Heales S J Clin Med. 2018; 7(2).
PMID: 29461488 PMC: 5852452. DOI: 10.3390/jcm7020036.
Neurodegeneration in Progressive Multiple Sclerosis.
Campbell G, Mahad D Cold Spring Harb Perspect Med. 2018; 8(10).
PMID: 29440322 PMC: 6169982. DOI: 10.1101/cshperspect.a028985.